CompareOpen in Google Play
This app isn't in any of our charts yet.
Bug fixes
You are invited to participate in the Daiichi Sankyo - DS7300-188 study.
A Phase 3, Multicenter, Randomized, Open Label Study Of Ifinatamab Deruxtecan (I Dxd), A B7-H3 Antibody Drug Conjugate (Adc), Versus Treatment Of Physician’s Choice (Tpc) In Subjects With Relapsed Small Cell Lung Cancer (Sclc). This app is specifically intended for participants in the ds7300-188 study only.
past month, based on 1 day
Downloads
Low confidence2
From install count ÷ months since release
In-app revenue
$0
No in-app purchases
Ads
$0
No ads
Total
$0
In-app + ads
Google Play only. Downloads from daily Top free ranks (or the store's install count); in-app revenue from Top grossing ranks, calibrated on AppTweak's US estimates, or else from downloads; ads from public ad benchmarks. Not reported figures.